Skip to main content

Table 3 Crude survival (%) after selected colon cancer diagnosed after initiation of colonoscopy surveillance and before age of 65 years for path_MLH1, path_MSH2 and path_MSH6 carriers with no cancer in any organ prior to, at, or within 1 year of their first colonoscopy

From: Survival by colon cancer stage and screening interval in Lynch syndrome: a prospective Lynch syndrome database report

Parameter 5-year survival (%) 95% CI (%) 10-year survival (%) 95% CI (%)
Interval
 Less than 1.5 years 89 [43–98] 89 [43–98]
 1.5 to 2.5 years 95 [83–99] 90 [75–96]
 2.5 to 3.5 years 94 [77–98] 90 [72–97]
 Over 3.5 years 92 [57–99] 92 [57–99]
Stage a
 I 98 [84–99.7] 93 [79–98]
 II 97 [80–99.6] 94 [78–98]
 III 82 [55–94] 82 [55–94]
  1. aIV: One path_MLH1 carrier who died before 5 years
Back to article page

Hereditary Cancer in Clinical Practice

ISSN: 1897-4287